Form 3 - Initial statement of beneficial ownership of securities
31 Décembre 2024 - 10:16PM
Edgar (US Regulatory)
EXHIBIT 24.1
POWER OF
ATTORNEY
KNOW ALL BY THESE PRESENTS,
that the undersigned hereby constitutes and appoints each of (i) Raza Bokhari, (ii) James Quinlan and (iii) Carolyn Bonner, signing SINGLY,
the undersigned’s true and lawful attorney-in-fact to:
(1) execute
for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director or holder of 10% or more of the registered
class of securities of Medicus Pharma Ltd. (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended, and the rules thereunder;
(2) do
and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such
Form 3, 4 or 5, complete and execute any amendment or amendments thereto and timely file such forms or amendments with the United States
Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take
any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit,
in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact
on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact’s discretion.
The undersigned hereby
grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary
or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, serving
in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities
to comply with Section 16 of the Exchange Act.
This Power of Attorney shall
remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s
holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.
* * * * *
IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed as of this 31st day of December, 2024.
|
By: |
/s/ Faisal Mehmud |
|
|
|
Name: Faisal Mehmud |
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicus Pharma (PK) (USOTC:MDPLF)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Medicus Pharma (PK) (USOTC:MDPLF)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025